| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 07/22/2010 | US20100184040 Compositions and methods for determining likelihood of twinning |
| 07/22/2010 | US20100184039 Methods and compositions relating to labeled rna molecules that reduce gene expression |
| 07/22/2010 | US20100184037 Death associated protein kinase 1 (dapk1) and uses thereof for the treatment of chronic lympocytic leukemia |
| 07/22/2010 | US20100184027 Methods and nucleic acids for analyses of cellular proliferative disorders |
| 07/22/2010 | US20100184022 Hybridization Probe Assay and Array |
| 07/22/2010 | US20100184021 Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis |
| 07/22/2010 | US20100184019 Novel Human Virus Causing Severe Acute Respiratory Syndrome (SARS) and Uses Thereof |
| 07/22/2010 | US20100184014 Non-M, non-O HIV-1 strains, fragments and uses |
| 07/22/2010 | US20100183766 Cgtase variants |
| 07/22/2010 | US20100183765 Asparaginase enzyme variants and uses thereof |
| 07/22/2010 | US20100183719 Surgical Applications for BMP Binding Protein |
| 07/22/2010 | US20100183704 dsRNA FOR TREATING VIRAL INFECTION |
| 07/22/2010 | US20100183696 Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists |
| 07/22/2010 | US20100183679 Primers for detecting plasmodium |
| 07/22/2010 | US20100183676 Compositions comprising opa protein epitopes |
| 07/22/2010 | US20100183670 Method for identifying motifs and/or combinations of motifs having a boolean state of predetermined mutation in a set of sequences and its application |
| 07/22/2010 | US20100183665 Promoterless cassettes for expression of alpha virus structural proteins |
| 07/22/2010 | US20100183656 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| 07/22/2010 | US20100183654 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis |
| 07/22/2010 | US20100183653 Fusion Proteins Comprising CD4 Minimal Modules and Methods of Use Thereof |
| 07/22/2010 | US20100183651 Broadly Representative Antigen Sequences and Method for Selection |
| 07/22/2010 | US20100183645 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 07/22/2010 | US20100183639 Nucleic acid-lipophilic conjugates |
| 07/22/2010 | US20100183637 fusion molecule based on novel taa variant |
| 07/22/2010 | US20100183634 Multifunctional nucleic acid nano-structures |
| 07/22/2010 | US20100183626 Human phospholipase a2 epsilon |
| 07/22/2010 | US20100183621 Fully human antibodies against human 4-1BB |
| 07/22/2010 | US20100183618 Anti-epha2 antibody |
| 07/22/2010 | US20100183616 Antibodies against interleukin-1 beta |
| 07/22/2010 | US20100183615 Cross-species-specific bispecific binders |
| 07/22/2010 | US20100183612 Methods of treatment using ctla4 mutant molecules |
| 07/22/2010 | US20100183610 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof |
| 07/22/2010 | US20100183590 LSA-5 liver stage and blood stage antigen of Plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 07/22/2010 | US20100183588 Mutated Netrin-4, Fragments Thereof And Their Use As Medicines |
| 07/22/2010 | US20100183584 Conformation and activity of gbeta5 complexes |
| 07/22/2010 | US20100183577 Enzyme replacement therapy for treating lysosomal storage diseases |
| 07/22/2010 | US20100183574 Lactic acid bacteria and their use in swine direct-fed microbials |
| 07/22/2010 | US20100183573 membrane polypeptide for use in designing therapeutic for proliferative, inflammatory, skin, arthritic, cardiovascular and autoimmune disorders; cancer, immunological-related, blood-related and skin-related disorders |
| 07/22/2010 | US20100183557 Ptra gene and uses thereof |
| 07/22/2010 | US20100183556 Recombinant expression vector system for variants of coagulation factor VIII and von Willebrand factor |
| 07/22/2010 | US20100183516 Self coupling recombinant antibody fusion proteins |
| 07/22/2010 | US20100183512 Use of cthrc1 in diagnosing cancer of liver |
| 07/21/2010 | EP2209000A2 Detection, monitoring and treatment of cancer |
| 07/21/2010 | EP2208793A1 Protein providing inducible resistance to glycopeptides, in particular in gram-positive bacteria |
| 07/21/2010 | EP2208736A2 Endogenous retrovirus up-regulated in prostate cancer |
| 07/21/2010 | EP2207787A2 Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties |
| 07/21/2010 | EP1581056B1 Therapeutic retroviral vectors for gene therapy |
| 07/21/2010 | EP0702566B1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 07/21/2010 | CN101784556A thiocarbon-protecting groups for rna synthesis |
| 07/20/2010 | US7759563 Plants and seeds of corn variety CV875318 |
| 07/20/2010 | US7759548 Polyunsaturated fatty acid production in heterologous organisms using PUFA polyketide synthase systems |
| 07/20/2010 | US7759513 Photolabile protective groups for improved processes to prepare oligonucleotide arrays |
| 07/20/2010 | US7759480 Chloral-free DCA in oligonucleotide synthesis |
| 07/20/2010 | US7759479 modulating the expression of a Gemin Gene; used in manufacture of a medicament for treatment of diseases and disorders |
| 07/20/2010 | US7759478 viral genomic address messenger (VGAM); selectively inhibit translation of known host target genes, and are believed to represent a novel pervasive viral attack mechanism |
| 07/20/2010 | US7759477 Immunoglobulin for use in detection of simian and lymphadenopathy associated viral infection in mammals; immunodiagnostics |
| 07/20/2010 | US7759476 Double-stranded RNAS directed to IKK-2 |
| 07/20/2010 | US7759475 Enzyme expression methods and compositions |
| 07/20/2010 | US7759474 used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 125P5C8 can be used in active or passive immunization |
| 07/20/2010 | US7759473 Nucleotide oligomer, nucleotide polymer, method for determining structure of functional substance and method for manufacturing functional substance |
| 07/20/2010 | US7759472 Administering platelet derived growth factor antagonist and endothelial growth factor antagonist |
| 07/20/2010 | US7759471 Monomer compositions for the synthesis of RNA, methods of synthesis, and methods of deprotection |
| 07/20/2010 | US7759470 Labeling reagent |
| 07/20/2010 | US7759469 substituted indole nucleosides as both terminal as well as internal building blocks of labeled oligonucleotide probes for the detection, analysis and quantitation of nucleic acids; nucleoside with a 3-substituted methanesulfonylamino indole as nucleobase |
| 07/20/2010 | US7759322 Method of treating dry eye disease with purinergic receptor agonists |
| 07/20/2010 | US7759320 Compositions and methods for inhibiting expression of a gene from the Ebola |
| 07/20/2010 | US7759319 Oligomeric compounds and compositions for use in modulation of pri-mirnas |
| 07/20/2010 | US7759303 Method for improving solubility and folding efficiency of target proteins using RNA as molecular chaperone |
| 07/20/2010 | US7759126 Real-time linear detection probes: sensitive 5′-minor groove binder-containing probes for amplification (or PCR) analysis |
| 07/20/2010 | US7759112 passing the mixture through a sintered glass frit under conditions effective to separate the nucleic acids from the extraneous matter |
| 07/20/2010 | US7759102 Talaromyces xylanases |
| 07/20/2010 | US7759100 polynucleotide expressed in Flammulina velutipes against 5,6-dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide |
| 07/20/2010 | US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 07/20/2010 | US7759090 Expression system for producing collagen |
| 07/20/2010 | US7759084 Transgenic cell models comprised of osmosensing histidine kinase for use in identifying fungicides; polynucleotide encoding the kinase; drug screening |
| 07/20/2010 | US7759071 Using nucleosome concentration after exposure to antitumor and/or anti-ischemic agents as diagnostic indicator of treatment efficacy |
| 07/20/2010 | US7759066 identifying an inhibitor of an agonist to receptors CCR2 and/or CCR5 (chemokine C-C motif receptor); signal transduction system in the G protein relating signal transduction in the CCL2-CCR2 pathway |
| 07/20/2010 | US7759064 primer pair H1511 and H1261 as a replacement for primer pair H279/H280 for specific amplification of cpn60 universal target sequences in genomic DNA or in complex DNA mixtures, including those with high G+C content |
| 07/20/2010 | US7759063 DNA-based functionalization of single walled carbon nanotubes for directed assembly |
| 07/20/2010 | US7759061 2′-nitrobenzyl-modified ribonucleotides |
| 07/20/2010 | US7759055 purifying sequencing reaction product by removing unincorporated dye terminators from a sequencing reaction; using a wash solution with effective amount of guanidine in a low ionic solution to reduce or eliminate the presence of dye terminators in a sequencing reaction product |
| 07/20/2010 | CA2424454C Cyanine dyes |
| 07/20/2010 | CA2340931C 3'-deoxypentopyranosylnucleic acid, its preparation and use |
| 07/20/2010 | CA2278786C Selection of proteins using rna-protein fusions |
| 07/20/2010 | CA2268740C High density immobilization of nucleic acids |
| 07/20/2010 | CA2197235C Adenovirus comprising a gene coding for glutathion peroxidase |
| 07/20/2010 | CA2105449C An interferon-.alpha./.beta. binding protein, its preparation and pharmaceutical compositions containing it |
| 07/15/2010 | WO2010080566A1 Methods and reagents for shortening incubation times in hybridization assays |
| 07/15/2010 | WO2010080129A2 Extended dicer substrate agents and methods for the specific inhibition of gene expression |
| 07/15/2010 | WO2010059226A3 Inhibition of map4k4 through rnai |
| 07/15/2010 | WO2010048552A3 Methods of using oligomeric compounds comprising 2'-substituted nucleosides |
| 07/15/2010 | WO2010046067A9 Improved allele-specific amplification |
| 07/15/2010 | WO2010036964A3 Modified animal erythropoietin polypeptides and their uses |
| 07/15/2010 | WO2008132723A3 Therapeutic delivery of inhibitory nucleic acid molecules to the respiratory system |
| 07/15/2010 | US20100180352 Compositions and Methods of Using RNA Interference for Control of Nematodes |
| 07/15/2010 | US20100179310 Genetic analysis of cells |
| 07/15/2010 | US20100179309 MODIFIED iRNA AGENTS |
| 07/15/2010 | US20100179092 Human complement c3 derivatives with cobra venom factor-like function |
| 07/15/2010 | US20100178649 Genomics-based quality diagnostics for prediction of cold-sweetenng during storage in processing potato |
| 07/15/2010 | US20100178348 Myostatin Inhibition for Enhancing Muscle and/or Improving Muscle Function |